Genzyme launches diagnostic to monitor Gleevec resistance.

doi:10.2217/14622416.7.3.267

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genzyme launches diagnostic to monitor Gleevec resistance.

Pharmacogenomics - 1 Apr 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Industry
Share to Drug Resistance, Neoplasm
Share to Benzamides
Share to Fusion Proteins, bcr-abl

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imatinib Mesylate

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Piperazines

Share to Pyrimidines

Source

Open in PubMed

Identifiers

PMID: 16610938
DOI: 10.2217/14622416.7.3.267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genzyme launches diagnostic to monitor Gleevec resistance.PMID 16610938Read ↗

Uncovering adagrasib resistance.Semantic proximity Read ↗

Update on resistance testing.Semantic proximity Read ↗

NGS reveals relevant resistance mutations.Semantic proximity Read ↗

Genomics uncovers microbe resistance.Semantic proximity Read ↗

Assess drug-resistance phenotypes, not just genotypes.Semantic proximity Read ↗

[Resistance screening].Semantic proximity Read ↗

Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining ChallengesSemantic proximity Read ↗

TKI resistance in Ph-like ALL.Semantic proximity Read ↗

Target gene mutation discovery and amplicon sequencing for evaluating maduramicin resistance in Eimeria tenella.Semantic proximity Read ↗

New data brings resistance testing closer to routine clinical use.Semantic proximity Read ↗

Clinical relevance of genotypic resistance testing today.Semantic proximity Read ↗

The value of resistance testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.